Member Info for Parpaing

It's here: https://www.facebook.com/NASDAQ/videos/vb.13881287428/10155064418242429/?type=2&theater

http://ir.xeneticbio.com/press-releases/detail/54

http://ir.xeneticbio.com/press-releases/detail/53

I hope this protection includes us. My shares have to be 29 USD each just to break even on the 'investment'.

This board needs a chuckle or two. Can you help?

Jam tomorrow. Expecting to report data in Q2, another trial starting in Q3 2017, Shire hopes to take their drug product to market (if all goes well) in 2020. I think I could discern three people applauding at the end of Scott's presentation.So lots of interest in our investment.

Maybe Scott has some good news to announce at the Roth conference tomorrow. Web conference is at 11:30 PDT. GLA.

SHP 656 aka BAX 826 is in a Phase 1 clinical trial started March 17 2016. The estimated study completion date is March 2017. This does not mean that we will learn the results of this trial. The trial is still recruiting patients.

Virexxa, aka XBIO 101 is in clinical trials sponsored by Kevelt AS, collaborator Pharmasyntez. The study is a Phase II Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma. Estimated Study Completion Date: 2018, but the Estimated Primary Completion Date is January 2018 (Final data collection date for primary outcome measure).

I haven't found any evidence that Oncohist is undergoing any clinical trials anywhere. Does anyone have any concrete and verifiable proof that Oncohist is in a clinical trial?

What did the secret service say when Donald Duck gets shot at? That made you trump !

After reading our company's product pipeline report, i decided to research the oncohist program, which is stated as being 'preclinical' for AML in the internal pipeline and phase to for AML and NHL with Synbio. Using the Internet, I can see all the government authorisations for all clinical trials and all drugs in Russia. There is no such authorisation for any company using the drugs / products named in our website. I can even see coded trials where the drug is not named but again I have drawn a blank. this may seem a negative point to some of you, but I don't believe that we as shareholders have been told the facts. It would appear, that yet again, Scott is being economical with the current events about Oncohist. It is very easy for me to check any clinical trial in Russia and I can see that there isn't any such trial taking place at the moment. Perhaps Scott would like to enlighten us about this subject.

I used to be able to make money in stocks and shares in the 1980s, when you and your broker had a gentleman's agreement. now, I believe the demise of the stock markets in general are due to the likes of Fred Goodwin and Shifty Green, when it is deemed OK to take shareholders (mugs) money and do whatever you like with it. Every stock on AIM and other markets is a loss for shareholders. ( I call it stealing). All you have to do is start a company on AIM, float it and say sorry when you have plundered everything. I know that there is a risk in stocks and shares but it would appear that every company is doing the same game and showing two fingers to shareholders. Plus, when I sold my worthless RBS shares i got a slap in the face by my broker who charged me more in fees than i received! Sorry about the gripe, but i actually believed that I was investing in this company. Ha ha ha!

Fingers crossed that some good news is revealed during the conference and that I don't waste my time and my youth listening to it.

http://ir.xeneticbio.com/press-releases/detail/45

http://ir.xeneticbio.com/press-releases/detail/45

The company Appoints Edward J. Benz, Jr., M.D., Former Dana-Farber CEO, to its Board of Directors see company website.

http://seekingalpha.com/article/4025285-xenetic-biosciences-small-biotech-large-partners-shareholders

Lord - no reply to two emails. the second email was along the lines of please explain the "public offering" that wasn't open to the public and particularly the long-term investor in the UK? How does that work and how come we haven't been allowed to take advantage of the warrants?

published today on the website: http://ir.xeneticbio.com/press-releases/detail/43